Cancer Treatment Centers of America deploys Intel's personal health system solution

NewsGuard 100/100 Score

Cancer Treatment Centers of America (CTCA) is deploying the Intel® Health Guide - a next-generation personal health system solution that allows physicians and clinicians to proactively monitor their patients' care at home - as part of its commitment to provide patients with the information and resources they need to make educated decisions about their cancer care.

“Our partnership with Intel allows us to proactively bring our services to patients in their homes while enabling them to participate in their own care”

CTCA will be able to gather timely information about the status of patients, and collect and prioritize data to monitor and modify their care while at home using the Intel Health Guide. Patients will be engaged in their own care through customizable educational content and access to their own health information, furthering efforts by CTCA to help patients take control of their cancer so that they can take control of their lives.

CTCA, a national provider of innovative cancer treatment for nearly 30 years, is currently deploying 100 Intel Health Guide systems to patients throughout the country as the latest initiative in its HopeLink program. The HopeLink program incorporates the key differentiating features of the Intel Health Guide such as video conferencing. Further, CTCA has enabled the seamless integration of patient data into the hospital network's electronic health record to provide both patients and oncology care team members with the information and resources they need to make informed decisions about cancer treatment and ongoing care. Patients and their health care teams can connect via any type of broadband connection.

"Our partnership with Intel allows us to proactively bring our services to patients in their homes while enabling them to participate in their own care," said Edgar Staren, MD, PhD, FACS, chief medical officer of CTCA. "This program is a natural extension of our fully integrated treatment model - Patient Empowered CareSM - which puts patients at the center of care, empowering them with information about their condition and treatment as they experience greater communication with and access to their care team."

"We are deeply committed to working with Cancer Treatment Centers of America to help them deliver quality healthcare and improve the lives of their patients with innovative technologies such as the Intel Health Guide," said Doug Busch, vice president and chief technology officer of Intel's Digital Health Group. "Allowing CTCA to stay connected to their patients in the home through the Intel Health Guide showcases our company's promise to support healthy, independent living in homes worldwide."

The Intel Health Guide combines an in-home patient device, the Intel® Health Guide PHS6000, with the Intel® Health Care Management Suite, an online interface that allows clinicians to securely monitor patients in their homes and manage care remotely. This solution is one of the assets that the Intel Digital Health Group is contributing to the new healthcare joint venture formed by GE Healthcare and Intel, which was announced on Aug. 2 and is expected to be operational by the end of the year, pending regulatory and other customary closing conditions.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases